N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Sponsor: Merck Sharp & Dohme LLC • ClinicalTrials.gov ID: NCT06966700

Registry updated: 2026-10-13
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back after treatment * Early-stage, which means the cancer is in the breast or the lymph nodes around the breast The 2 types of breast cancer in this study are triple-negative breast cancer (TNBC) and hormone receptor (HR)-low positive/human epidermal growth factor receptor-2 (HER2) negative breast cancer. These cancers have zero or a low amount of a protein called HER2 and other proteins that attach to the hormones estrogen or progesterone. Sacituzumab tirumotecan (also known as sac-TMT or MK-2870), the study medicine, is a type of targeted therapy. A targeted therapy is a treatment that works to control how specific types of cancer cells grow and spread. The main goals of this study are to learn if people who receive sac-TMT, pembrolizumab, and chemotherapy: * Have fewer cancer cells found in the tumors and lymph nodes removed during surgery compared to those who receive only pembrolizumab and chemotherapy * Live longer without the cancer growing, spreading, or coming back compared to people who receive only pembrolizumab with chemotherapy

Interventions

  • Sacituzumab tirumotecan (Biological)
    IV infusion
  • Pembrolizumab (Biological)
    IV infusion
  • Rescue Medication (Drug)
    Participants receive rescue medication at the investigators discretion, per approved product label. Recommended rescue medications are histamine -1 (H1) receptor agonist, histamine-2 (H2) receptor antagonist, acetaminophen or equivalent, dexamethasone or equivalent infusion, or steroid mouthwash (dexamethasone or equivalent).
  • Carboplatin (Drug)
    IV infusion
  • Paclitaxel (Drug)
    IV infusion
  • Doxorubicin (Drug)
    IV infusion
  • Epirubicin (Drug)
    IV infusion
  • Cyclophosphamide (Drug)
    IV infusion
  • Capecitabine (Drug)
    Oral tablet
  • Olaparib (Drug)
    Oral tablet

Eligibility criteria

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has previously untreated high-risk, early-stage, non-metastatic (M0) breast cancer (BC), defined as any of the following combined primary tumor (T) and regional lymph node (N) staging per AJCC 8th edition criteria as assessed by the physician investigator based on radiological and/or clinical assessment: * cT1c, N1-N2 * cT2, N0-N2 * cT3, N0-N2 * cT4a-d, N0-N2 * The participant must have a centrally confirmed diagnosis of BC that is triple-negative or HR-low+/HER2- (defined as estrogen receptor (ER)-low+ expression in 1% to 10% cells and HER2- as by the most recent American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines. * Provides a core needle biopsy from the primary breast tumor at screening to the central laboratory. * Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 performed within 28 days before Cycle1 Day 1 (C1D1). * Demonstrates adequate organ function. Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Metastatic (Stage IV) breast cancer or clinical node stage 3 (cN3) nodal involvement * Has received any prior treatment, including radiation, systemic therapy,and/or definitive surgery for currently diagnosed breast cancer * Has undergone excisional biopsy of the primary tumor, axillary lymph node dissection, and/or axillary sentinel lymph node biopsy prior to study treatment. * Received prior systemic anticancer therapy including investigational agents within 4 weeks before C1D1. * Received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent, or with an agent directed to another stimulatory or coinhibitory T-cell receptor (eg, CTLA-4, OX- 40, CD137). * Received prior treatment with a TROP2-targeted antibody-drug conjugate (ADC). * Received prior treatment with a topoisomerase I inhibitor-containing ADC. * Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention. * Known additional malignancy that is progressing or has required active treatment within the past 5 years. * Uncontrolled systemic disease. * History of (noninfectious) pneumonitis/interstitial lung disease that required steroids, has current pneumonitis/interstitial lung disease or has suspected interstitial lung disease (ILD) or pneumonitis that cannot be ruled out by standard diagnostic assessments at Screening..

Conditions

Breast Neoplasms Triple Negative Breast Neoplasms HR Low-Positive/HER2-Negative Breast Neoplasms

Locations

  • Banner MD Anderson Cancer Center ( Site 0066) — Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) — Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) — Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) — Burbank, California, United States
  • Community Cancer Institute ( Site 0100) — Clovis, California, United States
  • Providence Medical Foundation ( Site 0080) — Fullerton, California, United States
  • MemorialCare Health System - Long Beach Medical Center ( Site 9556) — Long Beach, California, United States
  • El Camino Hospital Cancer Center ( Site 0096) — Mountain View, California, United States
  • Hoag Memorial Hospital Presbyterian ( Site 0010) — Newport Beach, California, United States
  • Helios Clinical Research ( Site 0061) — Whittier, California, United States
  • Intermountain Health Cancer Center Saint Joseph ( Site 0062) — Denver, Colorado, United States
  • Rocky Mountain Cancer Centers (RMCC) ( Site 8006) — Denver, Colorado, United States
  • Intermountain Health St. Mary's Regional Hospital ( Site 0054) — Grand Junction, Colorado, United States
  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044) — Altamonte Springs, Florida, United States
  • Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida, United States
  • Bioresearch Partner ( Site 0072) — Hialeah, Florida, United States
  • Mayo Clinic Hospital ( Site 0013) — Jacksonville, Florida, United States
  • Florida Cancer Specialists - North ( Site 7002) — St. Petersburg, Florida, United States
  • City of Hope Cancer Center - Atlanta ( Site 0102) — Newnan, Georgia, United States
  • Southern Illinois Hospital Services ( Site 9554) — Carterville, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology ( Site 0084) — Fort Wayne, Indiana, United States
  • Franciscan Health ( Site 0077) — Indianapolis, Indiana, United States
  • Ochsner Clinic Foundation ( Site 0021) — New Orleans, Louisiana, United States
  • Louisiana State University Health Sciences Shreveport ( Site 0053) — Shreveport, Louisiana, United States
  • New England Cancer Specialists ( Site 0051) — Westbrook, Maine, United States
  • Mercy Medical Center - Baltimore ( Site 0015) — Baltimore, Maryland, United States
  • Massachusetts General Hospital Cancer Center ( Site 0091) — Boston, Massachusetts, United States
  • Dana Farber Cancer Institute ( Site 0090) — Boston, Massachusetts, United States
  • Saint Luke's Cancer Institute ( Site 0059) — Kansas City, Missouri, United States
  • Washington University Siteman Cancer Center ( Site 0031) — St Louis, Missouri, United States
  • Cancer Partners of Nebraska ( Site 0068) — Lincoln, Nebraska, United States
  • Optum Care Cancer Center ( Site 0050) — Las Vegas, Nevada, United States
  • Renown Regional Medical Center ( Site 0041) — Reno, Nevada, United States
  • Hackensack Univ Medical Center (HUMC) ( Site 0007) — Hackensack, New Jersey, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0076) — New Brunswick, New Jersey, United States
  • Altru Health System ( Site 0057) — Grand Forks, North Dakota, United States
  • Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027) — Cincinnati, Ohio, United States
  • Northwest Cancer Specialists (Compass Oncology) ( Site 8010) — Tigard, Oregon, United States
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016) — Charleston, South Carolina, United States
  • St Francis Cancer Center ( Site 0093) — Greenville, South Carolina, United States
  • Avera McKennan Hospital ( Site 0002) — Sioux Falls, South Dakota, United States
  • Avera Cancer Institute - Yankton ( Site 0089) — Yankton, South Dakota, United States
  • Tennessee Cancer Specialists ( Site 7001) — Knoxville, Tennessee, United States
  • SCRI Oncology Partners ( Site 7005) — Nashville, Tennessee, United States
  • Nashville General Hospital ( Site 0017) — Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center ( Site 0038) — Nashville, Tennessee, United States
  • Hendrick Medical Center ( Site 0009) — Abilene, Texas, United States
  • Texas Oncology - DFW ( Site 8009) — Dallas, Texas, United States
  • UT Southwestern ( Site 0092) — Dallas, Texas, United States
  • Texas Oncology - Northeast Texas ( Site 8002) — Flower Mound, Texas, United States
  • JPS Oncology and Infusion Center ( Site 0083) — Fort Worth, Texas, United States
  • Kelsey-Seybold Clinic ( Site 0042) — Houston, Texas, United States
  • Kelsey-Seybold Clinic ( Site 0088) — Houston, Texas, United States
  • Oncology Consultants P.A. ( Site 0073) — Houston, Texas, United States
  • Texas Tech University Health Sciences Center ( Site 0087) — Lubbock, Texas, United States
  • Texas Oncology - San Antonio ( Site 8004) — San Antonio, Texas, United States
  • Intermountain Medical Center ( Site 0074) — Murray, Utah, United States
  • Bon Secours Cancer Institute at St. Francis ( Site 0048) — Midlothian, Virginia, United States
  • Virginia Oncology Associates (VOA) ( Site 8008) — Norfolk, Virginia, United States
  • Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8005) — Roanoke, Virginia, United States
  • Fred Hutchinson Cancer Center ( Site 0069) — Seattle, Washington, United States
  • Cancer Care Northwest ( Site 0003) — Spokane, Washington, United States
  • Northwest Medical Specialties, PLLC ( Site 0067) — Tacoma, Washington, United States
  • University of Wisconsin-Madison ( Site 0024) — Madison, Wisconsin, United States
  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 6008) — Mar del Plata, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires-ginecology ( Site 6003) — Buenos Aires, Buenos Aires F.D., Argentina
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 6005) — Buenos Aires, Buenos Aires F.D., Argentina
  • Fundacion Ars Medica ( Site 6004) — San Salvador de Jujuy, Jujuy Province, Argentina
  • Sanatorio Parque ( Site 6002) — Rosario, Santa Fe Province, Argentina
  • Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L ( Site 6006) — San Miguel de Tucumán, Tucumán Province, Argentina
  • Sanatorio Finochietto ( Site 6007) — Buenos Aires, Argentina
  • Sanatorio Allende - Nueva Córdoba ( Site 6000) — Córdoba, Argentina
  • Sanatorio de la Cañada - Córdoba ( Site 6001) — Córdoba, Argentina
  • Chris O'Brien Lifehouse ( Site 1206) — Camperdown, New South Wales, Australia
  • Macquarie University ( Site 1203) — North Ryde, New South Wales, Australia
  • Westmead Hospital ( Site 1200) — Westmead, New South Wales, Australia
  • Monash Health ( Site 1201) — Clayton, Victoria, Australia
  • Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 3204) — Liège, Liege, Belgium
  • Jessa Ziekenhuis ( Site 3200) — Hasselt, Limburg, Belgium
  • AZORG Campus Aalst-Moorselbaan ( Site 3201) — Aalst, Oost-Vlaanderen, Belgium
  • UZ Gent ( Site 3202) — Ghent, Oost-Vlaanderen, Belgium
  • CHU UCL Namur/Site Sainte Elisabeth ( Site 3203) — Namur, Belgium
  • PRONUTRIR ( Site 6120) — Fortaleza, Ceará, Brazil
  • Hospital Araújo Jorge ( Site 6100) — Goiânia, Goiás, Brazil
  • Liga Norte Riograndense Contra o Câncer ( Site 6111) — Natal, Rio Grande do Norte, Brazil
  • Associação Hospitalar Beneficente São Vicente de Paulo ( Site 6115) — Passo Fundo, Rio Grande do Sul, Brazil
  • Irmandade da Santa Casa de Misericórdia de Porto Alegre ( Site 6102) — Porto Alegre, Rio Grande do Sul, Brazil
  • Hospital São Lucas da PUCRS ( Site 6103) — Porto Alegre, Rio Grande do Sul, Brazil
  • Clínica de Oncologia Reichow ( Site 6112) — Blumenau, Santa Catarina, Brazil
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 6108) — Barretos, São Paulo, Brazil
  • Hospital de Base de São José do Rio Preto ( Site 6101) — São José do Rio Preto, São Paulo, Brazil
  • INCA Hospital do Câncer III ( Site 6107) — Rio de Janeiro, Brazil
  • BC Cancer - Surrey ( Site 0217) — Surrey, British Columbia, Canada
  • BC Cancer Vancouver ( Site 0218) — Vancouver, British Columbia, Canada
  • NL Health Services ( Site 0232) — St. John's, Newfoundland and Labrador, Canada
  • Royal Victoria Regional Health Centre ( Site 0233) — Barrie, Ontario, Canada
  • Health Sciences North ( Site 0234) — Greater Sudbury, Ontario, Canada
  • Lakeridge Health ( Site 0225) — Oshawa, Ontario, Canada
  • The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0209) — Ottawa, Ontario, Canada
  • Sault Area Hospital ( Site 0226) — Sault Ste. Marie, Ontario, Canada
  • Princess Margaret Cancer Centre ( Site 0208) — Toronto, Ontario, Canada
  • Centre Hospitalier de l'Université de Montréal ( Site 0201) — Montreal, Quebec, Canada
  • Jewish General Hospital ( Site 0200) — Montreal, Quebec, Canada
  • McGill University Health Centre ( Site 0202) — Montreal, Quebec, Canada
  • CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0203) — Québec, Quebec, Canada
  • Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0206) — Sherbrooke, Quebec, Canada
  • Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0204) — Trois-Rivières, Quebec, Canada
  • Centro de Estudios Clínicos SAGA ( Site 6205) — Santiago, Region M. de Santiago, Chile
  • Fundación Arturo López Pérez ( Site 6200) — Santiago, Region M. de Santiago, Chile
  • Bradfordhill ( Site 6202) — Santiago, Region M. de Santiago, Chile
  • ONCOCENTRO APYS ( Site 6204) — Viña del Mar, Valparaiso, Chile
  • Anhui Provincial Cancer Hospital ( Site 2234) — Hefei, Anhui, China
  • Beijing Cancer Hospital ( Site 2201) — Beijing, Beijing Municipality, China
  • The First Affiliated hospital of Xiamen University-Breast Surgery ( Site 2224) — Xiamen, Fujian, China
  • Guangdong Maternity and Child Health Care Hospital ( Site 2251) — Guangzhou, Guangdong, China
  • Jiangmen Central Hospital ( Site 2243) — Jiangmen, Guangdong, China
  • Liuzhou People's Hospital ( Site 2259) — Liuzhou, Guangxi, China
  • Guangxi Medical University Affiliated Tumor Hospital ( Site 2223) — Nanning, Guangxi, China
  • Xingtai People's Hospital ( Site 2260) — Xingtai, Hebei, China
  • Harbin Medical University Cancer Hospital ( Site 2204) — Haerbin, Heilongjiang, China
  • Henan Cancer Hospital ( Site 2238) — Zhengzhou, Henan, China
  • Wuhan Union Hospital ( Site 2239) — Wuhan, Hubei, China
  • Renmin Hospital of Wuhan University ( Site 2236) — Wuhan, Hubei, China
  • Hunan Cancer Hospital ( Site 2232) — Changsha, Hunan, China
  • Xiangya Hospital of Central South University ( Site 2225) — Changsha, Hunan, China
  • Jiangsu Province Hospital ( Site 2216) — Nanjing, Jiangsu, China
  • Nanjing Drum Tower Hospital ( Site 2217) — Nanjing, Jiangsu, China
  • The Third Hospital Of Nanchang ( Site 2218) — Nanchang, Jiangxi, China
  • The First Hospital Of Jilin University ( Site 2207) — Changchun, Jilin, China
  • The First Affiliated Hospital of Xi'an Jiaotong University ( Site 2203) — Xi'an, Shaanxi, China
  • Jinan Central Hospital ( Site 2249) — Jinan, Shandong, China
  • Shandong Cancer Hospital ( Site 2205) — Jinan, Shandong, China
  • LinYi Cancer Hospital ( Site 2248) — Linyi, Shandong, China
  • Fudan University Shanghai Cancer Center ( Site 2209) — Shanghai, Shanghai Municipality, China
  • Deyang City People's Hospital ( Site 2244) — Deyang, Sichuan, China
  • The Second People's Hospital of Neijiang ( Site 2242) — Neijiang, Sichuan, China
  • Xinjiang Medical University Cancer Hospital - Urumqi ( Site 2230) — Ürümqi, Xinjiang, China
  • Yunnan Province Cancer Hospital ( Site 2226) — Kunming, Yunnan, China
  • The Second Affiliated Hospital Zhejiang University School of Medicine ( Site 2212) — Hangzhou, Zhejiang, China
  • Zhejiang Cancer Hospital ( Site 2211) — Hangzhou, Zhejiang, China
  • Zhejiang Provincial People's Hospital ( Site 2215) — Hangzhou, Zhejiang, China
  • Promotora Médica Las Américas S.A. ( Site 6302) — Medellín, Antioquia, Colombia
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 6311) — Bogotá, Bogota D.C., Colombia
  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 6309) — Bogotá, Bogota D.C., Colombia
  • IMAT S.A.S ( Site 6300) — Montería, Departamento de Córdoba, Colombia
  • Oncologos del Occidente ( Site 6303) — Pereira, Risaralda Department, Colombia
  • Fundación Valle del Lili ( Site 6308) — Cali, Valle del Cauca Department, Colombia
  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 3400) — Brno, Brno-mesto, Czechia
  • Nemocnice AGEL Novy Jicin a.s.-Oddeleni radioterapie a onkologie ( Site 3401) — Nový Jičín, Moravian-Silesian Region, Czechia
  • Fakultni nemocnice Hradec Kralove-Klinika onkologie a radioterapie ( Site 3403) — Hradec Králové, Czechia
  • Krajska nemocnice Liberec a.s.-Komplexni onkologicke centrum ( Site 3404) — Liberec, Czechia
  • Oulun yliopistollinen sairaala ( Site 3603) — Oulu, North Ostrobothnia, Finland
  • Tampereen ylipistollinen sairaala ( Site 3601) — Tampere, Pirkanmaa, Finland
  • Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 3600) — Helsinki, Uusimaa, Finland
  • Institut Paoli Calmettes. ( Site 3906) — Marseille, Bouches-du-Rhone, France
  • Centre Georges Francois Leclerc ( Site 3902) — Dijon, Bourgogne-Franche-Comté, France
  • Institut Curie - site Saint-Cloud ( Site 3909) — Saint-Cloud, Hauts-de-Seine, France
  • Centre de Cancerologie du Grand Montpellier ( Site 3910) — Montpellier, Herault, France
  • Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer-Medical Oncology ( Site 3900) — Rennes, Ille-et-Vilaine, France
  • centre hospitalier lyon sud ( Site 3901) — Pierre-Bénite, Rhone, France
  • CHU d'Amiens-Picardie - Hôpital Sud ( Site 3908) — Amiens, Somme, France
  • HENRI MONDOR HOSPITAL ( Site 3904) — Créteil, Val-de-Marne, France
  • Institut Curie ( Site 3903) — Paris, France
  • Universitaetsklinik Erlangen ( Site 4001) — Erlangen, Bavaria, Germany
  • Klinikum der Ludwig-Maximilians-Universitaet Muenchen ( Site 4015) — Munich, Bavaria, Germany
  • St. Vincenz-Krankenhaus Frauen- und Kinderklinik ( Site 4003) — Paderborn, North Rhine-Westphalia, Germany
  • InVO Institut für Versorgungsforschung in der Onkologie ( Site 4009) — Koblenz, Rhineland-Palatinate, Germany
  • CaritasKlinikum Saarbruecken St. Theresia ( Site 4014) — Saarbrücken, Saarland, Germany
  • Helios Klinikum Berlin-Buch ( Site 4008) — Berlin, Germany
  • General Hospital of Athens - Laiko ( Site 4104) — Athens, Attica, Greece
  • Aretaieio Hospital Oncology Unit ( Site 4101) — Athens, Attica, Greece
  • Metropolitan Hospital ( Site 4102) — Athens, Attica, Greece
  • ATHENS MEDICAL CENTER ( Site 4100) — Marousi, Attica, Greece
  • European Interbalkan Medical Center ( Site 4103) — Thessaloniki, Greece
  • MEDI-K ( Site 6400) — Guatemala City, Guatemala
  • CELAN,S.A ( Site 6401) — Guatemala City, Guatemala
  • INTEGRA Cancer Institute ( Site 6404) — Guatemala City, Guatemala
  • Onco Go, S.A ( Site 6402) — Guatemala City, Guatemala
  • Oncomedica ( Site 6405) — Guatemala City, Guatemala
  • Asociacion Española de Beneficencia ( Site 6403) — Guatemala City, Guatemala
  • Hong Kong United Oncology Centre ( Site 1304) — Jordan, Hong Kong
  • Queen Mary Hospital ( Site 1300) — Pokfulam, Hong Kong
  • Prince of Wales Hospital ( Site 1301) — Shatin, Hong Kong
  • Tuen Mun Hospital ( Site 1303) — Tuenmen, Hong Kong
  • Borsod-Abaúj-Zemplén Vármegyei Központi Kórház És Egyetemi Oktatókórház ( Site 4208) — Miskolc, Borsod-Abauj Zemplen county, Hungary
  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 4207) — Kecskemét, Bács-Kiskun county, Hungary
  • Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterapias Klinika ( Site 4202) — Szeged, Csongrád megye, Hungary
  • Zala Vármegyei Szent Rafael Kórház-Onkológiai osztály ( Site 4206) — Zalaegerszeg, Zala County, Hungary
  • Országos Onkológiai Intézet-B-Belgyógyászati Onkológiai Osztály ( Site 4204) — Budapest, Hungary
  • Basavatarakam Indo American Cancer Hospital & Research Institute ( Site 1408) — Hyderabad, Telangana, India
  • Rambam Health Care Campus ( Site 4400) — Haifa, Israel
  • Meir Medical Center. ( Site 4403) — Kfar Saba, Israel
  • Sheba Medical Center ( Site 4401) — Ramat Gan, Israel
  • Yitzhak Shamir Medical Center. ( Site 4404) — Ẕerifin, Israel
  • Fondazione IRCCS San Gerardo dei Tintori ( Site 4513) — Monza, Lombardy, Italy
  • Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno ( Site 4503) — Livorno, Tuscany, Italy
  • Azienda Ospedaliero Universitaria delle Marche ( Site 4509) — Ancona, Italy
  • ASST Papa Giovanni XXIII ( Site 4511) — Bergamo, Italy
  • IRCCS Azienda Ospedaliera Metropolitana ( Site 4508) — Genova, Italy
  • Ospedale San Raffaele di Milano ( Site 4515) — Milan, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 4501) — Milan, Italy
  • Istituto Oncologico Veneto IRCCS ( Site 4505) — Padova, Italy
  • Azienda Ospedaliero Universitaria Pisana ( Site 4506) — Pisa, Italy
  • Arcispedale Santa Maria Nuova ( Site 4510) — Reggio Emilia, Italy
  • Istituto Nazionale Tumori Regina Elena ( Site 4512) — Roma, Italy
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 4500) — Roma, Italy
  • Nagoya City University Hospital ( Site 2310) — Nagoya, Aichi-ken, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 2319) — Matsuyama, Ehime, Japan
  • National Hospital Organization Hokkaido Cancer Center ( Site 2300) — Sapporo, Hokkaido, Japan
  • Kanazawa Medical University Hospital ( Site 2321) — Kahoku-gun, Ishikawa-ken, Japan
  • Kanagawa Cancer Center ( Site 2308) — Yokohama, Kanagawa, Japan
  • Mie University Hospital ( Site 2312) — Tsu, Mie-ken, Japan
  • Naha Nishi Clinic ( Site 2320) — Naha, Okinawa, Japan
  • Kansai Medical University Hospital ( Site 2317) — Hirakata, Osaka, Japan
  • Kindai University Hospital ( Site 2316) — Sakai, Osaka, Japan
  • The University of Osaka Hospital ( Site 2314) — Suita, Osaka, Japan
  • Shizuoka Cancer Center ( Site 2309) — Sunto-gun, Shizuoka, Japan
  • National Cancer Center Hospital ( Site 2305) — Chūō, Tokyo, Japan
  • Toranomon Hospital ( Site 2307) — Minato, Tokyo, Japan
  • Showa Medical University Hospital ( Site 2306) — Shinagawa, Tokyo, Japan
  • Akita University Hospital ( Site 2302) — Akita, Japan
  • Chiba Cancer Center ( Site 2303) — Chiba, Japan
  • Fukushima Medical University Hospital ( Site 2301) — Fukushima, Japan
  • Hiroshima City Hiroshima Citizens Hospital ( Site 2318) — Hiroshima, Japan
  • Kumamoto Shinto General Hospital ( Site 2322) — Kumamoto, Japan
  • Kyoto University Hospital ( Site 2313) — Kyoto, Japan
  • Nakagami Hospital ( Site 2323) — Okinawa, Japan
  • National Hospital Organization Osaka National Hospital ( Site 2315) — Osaka, Japan
  • University Malaya Medical Centre. ( Site 1503) — Lembah Pantai, Kuala Lumpur, Malaysia
  • Hospital Pulau Pinang ( Site 1502) — George Town, Pulau Pinang, Malaysia
  • National Cancer Institute ( Site 1501) — Putrajaya, Putrajaya, Malaysia
  • Sarawak General Hospital ( Site 1504) — Kuching, Sarawak, Malaysia
  • Pantai Hospital Kuala Lumpur ( Site 1500) — Kuala Lumpur, Malaysia
  • Bowen Icon Cancer Centre ( Site 1001) — Crofton Downs, Wellington Region, New Zealand
  • Auckland City Hospital ( Site 1000) — Auckland, New Zealand
  • Akershus Universitetssykehus ( Site 3701) — Lørenskog, Akershus, Norway
  • Drammen Sykehus, Vestre Viken HF ( Site 3700) — Drammen, Buskerud, Norway
  • Nordlandssykehuset ( Site 3704) — Bodø, Nordland, Norway
  • Stavanger Universitetssjukehus ( Site 3702) — Stavanger, Rogaland, Norway
  • Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 6605) — Concepción, Departamento de Junín, Peru
  • Instituto Regional de Enfermedades Neoplásicas Del Norte ( Site 6606) — Trujillo, La Libertad, Peru
  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 6604) — Surquillo, Muni Metro de Lima, Peru
  • Hospital Guillermo Almenara Irigoyen ( Site 6601) — Lima, Peru
  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 6600) — Lima, Peru
  • Oncosalud ( Site 6603) — Lima, Peru
  • Hospital Nacional Edgardo Rebagliati Martins ( Site 6602) — Lima, Peru
  • Makati Medical Center ( Site 1609) — Makati City, National Capital Region, Philippines
  • THE MEDICAL CITY ( Site 1602) — Pasig, National Capital Region, Philippines
  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 4616) — Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 4612) — Krakow, Lesser Poland Voivodeship, Poland
  • Specjalistyczny Szpital im. dra A. Sokolowskiego w Walbrzychu ( Site 4604) — Wałbrzych, Lower Silesian Voivodeship, Poland
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 4609) — Warsaw, Masovian Voivodeship, Poland
  • Bialostockie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 4608) — Bialystok, Podlaskie Voivodeship, Poland
  • Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku ( Site 4600) — Słupsk, Pomeranian Voivodeship, Poland
  • Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 4614) — Olsztyn, Warmian-Masurian Voivodeship, Poland
  • Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie ( Site 4611) — Koszalin, West Pomeranian Voivodeship, Poland
  • Salve Medica sp. z o.o. sp. k. ( Site 4618) — Lodz, Łódź Voivodeship, Poland
  • Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 4619) — Kielce, Świętokrzyskie Voivodeship, Poland
  • Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 4702) — Lisbon, Lisbon District, Portugal
  • Hospital de Cascais Doutor José de Almeida ( Site 4700) — Lisbon, Portugal
  • Instituto Portugues de Oncologia do Porto ( Site 4705) — Porto, Portugal
  • Unidade Local de Saúde de São João ( Site 4703) — Porto, Portugal
  • SC Radiotherapy Center Cluj SRL ( Site 4808) — Cluj-Napoca, Cluj, Romania
  • Cabinet Medical Oncomed ( Site 4803) — Timișoara, Timiș County, Romania
  • Spitalul Clinic Filantropia ( Site 4801) — Bucharest, Romania
  • Institutul Oncologic Cluj ( Site 4802) — Cluj-Napoca, Romania
  • Institutul Regional de Oncologie ( Site 4805) — Iași, Romania
  • King Faisal Specialist Hospital and Research Center ( Site 5400) — Riyadh, Riyadh Region, Saudi Arabia
  • National Cancer Centre Singapore ( Site 1700) — Singapore, Central Singapore, Singapore
  • CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 4907) — Port Elizabeth, Eastern Cape, South Africa
  • Wits Clinical Research ( Site 4903) — Johannesburg, Gauteng, South Africa
  • LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 4901) — Pretoria, Gauteng, South Africa
  • Sandton Oncology Medical Group (Pty) Ltd ( Site 4900) — Sandton, Gauteng, South Africa
  • Cancercare Rondebosch Oncology ( Site 4906) — Cape Town, Western Cape, South Africa
  • National Cancer Center ( Site 1800) — Goyang-si, Kyonggi-do, South Korea
  • Seoul National University Bundang Hospital ( Site 1801) — Kyonggi-do, Kyonggi-do, South Korea
  • Kyungpook National University Chilgok Hospital ( Site 1805) — Taegu, Taegu-Kwangyokshi, South Korea
  • Seoul National University Hospital ( Site 1806) — Seoul, South Korea
  • Severance Hospital Yonsei University Health System ( Site 1804) — Seoul, South Korea
  • Asan Medical Center ( Site 1803) — Seoul, South Korea
  • Samsung Medical Center ( Site 1807) — Seoul, South Korea
  • The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 1802) — Seoul, South Korea
  • Institut Català d'Oncologia - L'Hospitalet ( Site 5001) — L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital de Basurto ( Site 5007) — Bilbao, Bizkaia, Spain
  • Complejo asistencial universitario de Salamanca ( Site 5000) — Salamanca, Castille and León, Spain
  • HOSPITAL UNIVERSITARIO DE JAEN ( Site 5003) — Jaén, Jaen, Spain
  • CHUS - Hospital Clinico Universitario ( Site 5006) — Santiago de Compostela, La Coruna, Spain
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 5004) — Pozuelo de Alarcón, Madrid, Spain
  • Hospital General de Valencia ( Site 5008) — Valencia, Valenciana, Comunitat, Spain
  • Parc de Salut Mar - Hospital del Mar ( Site 5005) — Barcelona, Spain
  • Hospital Beata María Ana ( Site 5010) — Madrid, Spain
  • Hospital Universitario Virgen Macarena ( Site 5002) — Seville, Spain
  • Skånes Universitetssjukhus Malmö ( Site 3802) — Malmö, Skåne County, Sweden
  • Karolinska Universitetssjukhuset Solna ( Site 3800) — Stockholm, Stockholm County, Sweden
  • Akademiska sjukhuset ( Site 3801) — Uppsala, Uppsala County, Sweden
  • Södra Älvsborgs Sjukhus Borås ( Site 3804) — Borås, Västra Götaland County, Sweden
  • Taichung Veterans General Hospital ( Site 1904) — Taichung, Taiwan
  • National Taiwan University Hospital ( Site 1900) — Taipei, Taiwan
  • MacKay Memorial Hospital ( Site 1903) — Taipei, Taiwan
  • National Taiwan University Cancer Center (NTUCC) ( Site 1901) — Taipei, Taiwan
  • Chang Gung Medical Foundation-Linkou Branch ( Site 1906) — Taoyuan, Taiwan
  • Faculty of Medicine Siriraj Hospital ( Site 2000) — Bangkok, Bangkok, Thailand
  • Chulalongkorn University ( Site 2001) — Pathumwan, Bangkok, Thailand
  • Songklanagarind Hospital ( Site 2002) — Hat Yai, Changwat Songkhla, Thailand
  • Maharaj Nakorn Chiang Mai Hospital ( Site 2003) — Muang, Chiang Mai, Thailand
  • Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 5110) — Sıhhiye, Ankara, Turkey (Türkiye)
  • Basken Adana Dr.Turgut Noyan Uygulama ve Arastirma Merkezi. ( Site 5112) — Adana, Turkey (Türkiye)
  • Memorial Ankara Hastanesi ( Site 5116) — Ankara, Turkey (Türkiye)
  • Ankara Bilkent Şehir Hastanesi. ( Site 5114) — Ankara, Turkey (Türkiye)
  • I.U. Cerrahpasa Medical Faculty ( Site 5111) — Istanbul, Turkey (Türkiye)
  • Bakirkoy Dr. Sadi Konuk Training and Research Hospital ( Site 5117) — Istanbul, Turkey (Türkiye)
  • Erciyes University ( Site 5119) — Kayseri, Turkey (Türkiye)
  • Mersin Sehir Eğitim ve Araştırma Hastanesi ( Site 5123) — Mersin, Turkey (Türkiye)
  • Samsun Medical Park Hastanesi ( Site 5121) — Samsun, Turkey (Türkiye)
  • COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 5207) — Cherkasy, Cherkasy Oblast, Ukraine
  • Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 5208) — Chernivtsi, Chernivetska Oblast, Ukraine
  • CNCE Precarpathian Clinical Oncologic Center ( Site 5201) — Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
  • CNE Regional clinical oncology center of Kirovograd regional Council ( Site 5203) — Kropyvnytsky, Kirovohrad Oblast, Ukraine
  • Shalimov Institute of Surgery and Transplantation ( Site 5210) — Kyiv, Ukraine
  • University College London Hospital ( Site 5301) — London, Camden, United Kingdom
  • Ninewells Hospital and Medical School ( Site 5300) — Dundee, Dundee City, United Kingdom
  • Huddersfield Royal Infirmary ( Site 5313) — Huddersfield, England, United Kingdom
  • Colchester General Hospital ( Site 5307) — Colchester, Essex, United Kingdom
  • Princess Royal University Hospital ( Site 5316) — Orpington, Kent, United Kingdom
  • St Bartholomew s Hospital ( Site 5302) — London, London, City of, United Kingdom
  • Nottingham University Hospitals NHS Trust ( Site 5314) — Nottingham, Nottinghamshire, United Kingdom
  • Blackpool Victoria Hospital ( Site 5310) — Blackpool, United Kingdom
  • Leicester Royal Infirmary ( Site 5309) — Leicester, United Kingdom
  • Hanoi Oncology Hospital ( Site 2101) — Hanoi, Hanoi, Vietnam
  • K Hospital - National Cancer Hospital ( Site 2100) — Hanoi, Hanoi, Vietnam
  • Oncology Hospital ( Site 2102) — Ho Chi Minh City, Ho Chi Minh, Vietnam
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record